Skip to content

CHOP, ECHOP and EPOCH for the treatment in non-Hodgkin's lymphoma (NHL)

CHOP, ECHOP and EPOCH for the treatment in non-Hodgkin's lymphoma (NHL)

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-08000110
Enrollment
Unknown
Registered
2008-04-01
Start date
2003-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-Hodgkin's lymphoma

Interventions

CHOP group:chemo-treatment with CHOP program
ECHOP group:chemo-treatment with CHOP program

Sponsors

Fujian Provincial Tumour Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who were certified NHL definitely with Pathologic diagnosis and have no contraindication of chemo-treatment

Exclusion criteria

Exclusion criteria: The patients who have contraindication of chemo-treatment

Design outcomes

Primary

MeasureTime frame
Disease-free survival;Survival rat;

Secondary

MeasureTime frame
Tumor respons;

Countries

China

Contacts

Public ContactShen Yongqi
215871582@qq.com+86 013215971475

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026